Shlomo Brook

Summary

Affiliation: University of the Witwatersrand
Country: South Africa

Publications

  1. ncbi Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia
    Shlomo Brook
    Department of Psychiatry, Sterkfontein Hospital, Krugersdorp, South Africa
    J Clin Psychiatry 64:13-8. 2003
  2. ncbi Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study
    Shlomo Brook
    Department of Psychiatry, Sterkfontein Hospital, P O Box 2368, Krugersdorp, South Africa, 1740
    Psychopharmacology (Berl) 178:514-23. 2005
  3. ncbi A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia
    Alan Breier
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, DC 1748, Indianapolis, IN 46285, USA
    Arch Gen Psychiatry 59:441-8. 2002
  4. ncbi Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
    Istvan Bitter
    Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary
    Prog Neuropsychopharmacol Biol Psychiatry 28:173-80. 2004
  5. ncbi Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data
    Leslie Citrome
    Nathan S Kline Institute for Psychiatric Research and the New York University School of Medicine, Orangeburg, NY 10962, USA
    J Clin Psychiatry 67:638-42. 2006

Detail Information

Publications5

  1. ncbi Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia
    Shlomo Brook
    Department of Psychiatry, Sterkfontein Hospital, Krugersdorp, South Africa
    J Clin Psychiatry 64:13-8. 2003
    ..IM ziprasidone represents an important advance over older, conventional IM agents in the treatment of the acutely ill patient with schizophrenia...
  2. ncbi Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study
    Shlomo Brook
    Department of Psychiatry, Sterkfontein Hospital, P O Box 2368, Krugersdorp, South Africa, 1740
    Psychopharmacology (Berl) 178:514-23. 2005
    ..Conventional intramuscular (IM) antipsychotics used in managing acute exacerbation of schizophrenia are associated with side effects such as acute dystonia...
  3. ncbi A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia
    Alan Breier
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, DC 1748, Indianapolis, IN 46285, USA
    Arch Gen Psychiatry 59:441-8. 2002
    ..An intramuscular (IM) formulation of olanzapine has been developed because there are no rapid-acting IM atypical antipsychotic drugs currently available in the United States for treating acute agitation in patients with schizophrenia...
  4. ncbi Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
    Istvan Bitter
    Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary
    Prog Neuropsychopharmacol Biol Psychiatry 28:173-80. 2004
    ..Olanzapine therefore presents a safe alternative in the treatment of refractory schizophrenia...
  5. ncbi Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data
    Leslie Citrome
    Nathan S Kline Institute for Psychiatric Research and the New York University School of Medicine, Orangeburg, NY 10962, USA
    J Clin Psychiatry 67:638-42. 2006
    ..The objective was to determine the effects of sequential intramuscular/oral ziprasi-done on hostility...